Commentary · 21 Feb 2026
Conference abstractPublished 21 Oct 2013
The effect of chemotherapeutic agents on telomere maintenance in Breast cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Telomeres are made up of G-rich nucleotide repeats of the sequence TTAGGG that protect chromosome ends in mammalian cells. A six-protein complex called Shelterin packages telomeric DNA and helps to hide the chromosome ends from being recognized as sites of DNA damage during replication. It is well known that cancer is implicated with short telomeres and the telomerase enzyme is activated in 90% of cancers including breast cancer, but the length of telomeres is short suggesting that telomerase is responsible for telomere maintenance. Short telomere in breast cancer cells confers telomere dysfunction and this can be related to Shelterin proteins and their level of expression in breast cancer cells. Our studies have shown that Shelterin genes are down-regulated in breast cancer cell lines; therefore, to understand a possible mechanism behind the loss of ?Shelterin? expression, these genes may possibly be under the control of methylation in some epithelial breast cancer cells. Treatment of the 21NT breast cancer cell line with the demethylating agent 5-aza-CdR (5-Aza-2'-deoxycytidine) and TSA (Trichostatin A) resulted in up-regulation of the expression of shelterin genes. Based on these findings, the telomere length of 21NT at different time points of treatment was measured by FLOW-FISH, Q-FISH, Southern blot, and Q-PCR. Our results represent increase telomere length of 21NT cell line which was treated by 5-aza-CdR after 72 hours and 3 weeks. Therefore, increases in some of Shelterin gene expression can stabilize telomere length elongation.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Azadeh Motevalli”
